Healthcare Sales & Marketing Network News: Acute Myocardial Infarction

Searching News Database: Acute Myocardial Infarction

HSMN NewsFeed - 14 May 2020
U.S. Centers for Medicare & Medicaid Services (CMS) Proposes Extending New Technology Add-on Payment (NTAP) Reimbursement for Portola Pharmaceuticals' Andexxa(R) for Third Year
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 6 May 2020
FDA Clears New Mechanical Thrombectomy Platform
Devices Interventional FDA

HSMN NewsFeed - 7 Apr 2020
Portola Pharmaceuticals Announces the Establishment of a Permanent J-code for Andexxa by the Centers for Medicare & Medicaid Services, Effective July 1, 2020
Biopharmaceuticals Reimbursement

HSMN NewsFeed - 5 Mar 2020
New Data Demonstrates Andexxa(R) Can Provide a Net Cost Reduction for the Treatment of Intracranial Hemorrhage Associated with Oral Factor Xa Inhibitors
Biopharmaceuticals

HSMN NewsFeed - 4 Sep 2018
Miracor Medical closes final tranche of Series-D, bringing the round to €30M
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 23 Jul 2018
MEDICALgorithmics, Medi-Lynx Receive FDA 510(K) Clearance for PocketECG CRS Mobile Cardiac Rehabilitation System
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 27 Jun 2018
Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High- sensitivity Access hsTnI Assay
Diagnostics Cardiology FDA

HSMN NewsFeed - 24 May 2018
PiCSO therapy reduces infarct size in STEMI patients
Devices Interventional Cardiology

HSMN NewsFeed - 13 Feb 2018
Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock
Devices Cardiology FDA

HSMN NewsFeed - 12 Dec 2017
Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia
Biopharmaceuticals Cardiology Licensing

HSMN NewsFeed - 25 Oct 2016
Miracor Receives Additional Funding in Series-C Closing to Expand Clinical and Commercial Activities with the PiCSO(R) Impulse System
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 14 Sep 2016
European Commission Approves CABOMETYX(TM) (cabozantinib) Tablets for the Treatment of Advanced Renal Cell Carcinoma Following VEGF-Targeted Therapy
Biopharmaceuticals Oncology Regulatory

HSMN NewsFeed - 5 Jul 2016
Takeda and TiGenix Enter into Licensing Agreement for Ex-U.S. Rights to Cx601 for the Treatment of Complex Perianal Fistulas in Patients with Crohn's Disease
Biopharmaceuticals Regenerative Medicine Licensing

HSMN NewsFeed - 2 May 2016
Corsens Medical Ltd., Announces Filing of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Corsens Cardiac Monitor
Devices Cardiology Monitoring FDA

HSMN NewsFeed - 4 Apr 2016
First Approval by U.S. Food and Drug Administration for Contrast Enhanced Ultrasonography of the Liver Received by Bracco Diagnostics Inc. for LUMASON(R) (sulfur hexafluoride lipid-type A microspheres) for Injectable Suspension, for Intravenous Use
Biopharmaceuticals Radiology FDA

HSMN NewsFeed - 8 Feb 2016
STENTYS initiates the Commercialization of the first Self-Expanding Drug-Eluting stent for the Below-The-Knee Indication
Devices Interventional Product Launch

HSMN NewsFeed - 10 Dec 2015
Antonio Colombo, MD appointed Member of the Scientific Advisory Council of Miracor Medical Systems
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 11 Nov 2015
Recardio Secures $3 Million in Series A Financing, Relocates Headquarters to San Francisco
Regenerative Medicine Cardiology Venture Capital

HSMN NewsFeed - 5 Nov 2015
TherOx Receives FDA IDE Approval for Study of Next-Generation Supersaturated Oxygen Therapy for AMI
Devices Interventional Cardiology FDA

HSMN NewsFeed - 21 Sep 2015
Miracor Medical Systems Launches PiCSO(R) Impulse System in Asia
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 30 Mar 2015
The Medicines Company Receives European Commission Approval for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(R) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Nov 2014
BioCardia(R), Inc. Announces FDA Acceptance of Phase III Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy for Heart Failure Patients
Regenerative Medicine Cardiology FDA

HSMN NewsFeed - 30 Oct 2014
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 24 Jul 2014
Bioheart Announces World's First Combination Stem Cell Treatment
Regenerative Medicine Cardiology

HSMN NewsFeed - 20 May 2014
STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
Devices Interventional Cardiology

HSMN NewsFeed - 24 Apr 2014
Endo Acquires Rights to Sumavel(R) DosePro(R)
Biopharmaceuticals Drug Delivery Acquisitions

HSMN NewsFeed - 17 Mar 2014
BioCardia(R) Receives CE Mark for Morph AccessPro(TM) Steerable Introducer
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 7 Feb 2014
Covis Pharmaceuticals Announces Its New Expanded Dosage Options of LANOXIN(R) for Cardiac Patients With Mild-to-Moderate Heart Failure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Jan 2014
Bioheart Announces First Adipose Derived Stem Cell Implantation in Azerbaijan
Regnerative Medicine

HSMN NewsFeed - 8 Jan 2014
STENTYS Expands Marketing of its Stents in Asia
Devices Interventional Cardiology Distribution

HSMN NewsFeed - 6 Jan 2014
FDA Reclassifies ECP Devices for Refractory Angina as Class II
Devices Cardiology FDA

HSMN NewsFeed - 4 Nov 2013
Supersaturated Oxygen Therapy IDE Study Results in Smaller Infarct Size for Next-Generation System
Devices Interventional Cardiology

HSMN NewsFeed - 30 Oct 2013
The Medicines Company's EUROMAX Trial of Angiox(R) (Bivalirudin) in Heart Attack Meets All Prespecified Endpoints
Biopharmaceuticals Cardiology

HSMN NewsFeed - 25 Oct 2013
Bioheart Announces Agreement With Anosis to Distribute Products in the Middle East
Regenerative Medicine Cardiology Distribution

HSMN NewsFeed - 28 Aug 2013
Sheldon T. Anderson Elected to the Board of Directors of Bioheart, Inc.
Regenerative Medicine Cardiology Personnel

HSMN NewsFeed - 24 Jul 2013
FDA Grants Diazyme 510(k) Clearance to Market Its Myoglobin Assay for Clinical Chemistry Analyzers
Diagnostics Cardiology FDA

HSMN NewsFeed - 10 Jul 2013
STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 30 May 2013
Orsiro From BIOTRONIK, Industry's First Hybrid Drug-Eluting Stent, Performs as Best in Class
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2013
InspireMD Announces Reimbursement Coverage for MGuard(TM) Coronary Embolic Protection Stent
Devices Interventional Cardiology Reimbursement

HSMN NewsFeed - 27 Mar 2013
Bioheart's Appeals to the FDA for Compassionate Use Designation to Save Lives
Regenerative Medicine Cardiology FDA

HSMN NewsFeed - 19 Mar 2013
Bioheart Expands Center of Excellence Program
Regenerative Medicine Cardiology

HSMN NewsFeed - 9 Jan 2013
Velomedix Receives Health Canada Approval for VELOCITY Pilot Study and Bolsters Leadership Team
Devices Cardiology Regulatory

HSMN NewsFeed - 29 Oct 2012
Bioheart to Initiate ANGEL Trial in Mexico
Regenerative Medicine Cardiology

HSMN NewsFeed - 22 Oct 2012
STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing(R) Stent
Devices Interventional Cardiology FDA

HSMN NewsFeed - 22 Oct 2012
STENTYS Self-Apposing(R) Stent Continues to Demonstrate Low Mortality at One Year in APPOSITION III Trial
Devices Interventional Cardiology

HSMN NewsFeed - 11 Oct 2012
Pfizer Announces Top-Line Results From A Phase 3 Long-Term Safety Study Of ALO-02:
Biopharmaceuticals

HSMN NewsFeed - 28 Aug 2012
Latest European Heart Attack Treatment Guidelines Recommend Angiomax(R)/Angiox(R) (Bivalirudin) Over Heparin
Biopharmaceuticals Cardiology

HSMN NewsFeed - 27 Aug 2012
MAQUET Cardiovascular Announces Results Of The IABP-SHOCK II Trial Of Intra-aortic Balloon Counterpulsation Therapy In Cardiogenic Shock Patients
Devices Cardiology

HSMN NewsFeed - 5 Jun 2012
Asher Holzer Retires as President of InspireMD
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 25 May 2012
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
Devices Interventional Cardiology Endocrinology

HSMN NewsFeed - 16 May 2012
STENTYS Self-Apposing(R) Stent shows very low mortality at one month in 1,000 high-risk heart attack patients
Devices Interventional Cardiology

HSMN NewsFeed - 14 May 2012
STENTYS Expands Its Product Offerings for Treating Heart Attacks
Devices Interventional Cardiology

HSMN NewsFeed - 7 May 2012
Kerberos to Sell FDA Cleared Rinspiration Technology
Devices Interventional Cardiology

HSMN NewsFeed - 12 Apr 2012
Abiomed Receives CE Mark for Impella cVAD
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 9 Apr 2012
InspireMD Appoints Robert Ratini as Vice President of Sales and Marketing
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 23 Mar 2012
VectraCor Receives FDA Approval for Real-Time Detection of ECG Changes Suggestive of AMI
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 28 Feb 2012
Bioheart Announces University of Miami as Clinical Site for ANGEL Trial of LipiCell(TM)
Regenerative Medicine Cardiology

HSMN NewsFeed - 23 Feb 2012
Boston Scientific Receives Industry's First FDA Approval for Drug-Eluting Coronary Stent Use in Heart Attack Patients
Devices Interventional Cardiology FDA

HSMN NewsFeed - 15 Feb 2012
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
Biopharmaceuticals Neurology Regenerative Medicine

HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Regenerative Medicine Cardiology

HSMN NewsFeed - 8 Feb 2012
Velomedix Closes New Financing, Strengthens Leadership Team
Devices Cardiology Neurology Venture Capital Personnel

HSMN NewsFeed - 30 Jan 2012
Cytori Receives Approval From FDA to Initiate U.S. Cardiac Cell Therapy Trial; Investigational Device Exemption (IDE) Approved for ATHENA
Regenerative Medicine Cardiology

HSMN NewsFeed - 24 Jan 2012
Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American College of Cardiology; Cytori's APOLLO Trial Demonstrated Safety & Feasibility and Improvements in Cardiac Function
Regenerative Medicine Cardiology

HSMN NewsFeed - 14 Nov 2011
Athersys Announces Recovery of All Rights to Cardiovascular Cell Therapy Program
Regenerative Medicine Cardiology

HSMN NewsFeed - 21 Sep 2011
Vasomedical Announces Corporate Restructure and Appointment of New Chief Financial Officer
Devices Personnel

HSMN NewsFeed - 21 Sep 2011
STENTYS Completes Enrollment of APPOSITION III Study for its Self-Apposing Stent to Treat Heart Attacks
Devices Interventional Cardiology

HSMN NewsFeed - 19 Sep 2011
Abiomed Announces First Patient Enrolled In MINI-AMI Study
Devices Cardiology

HSMN NewsFeed - 23 Aug 2011
Vasomedical Announces Agreement to Acquire Two China-based Companies
Devices Mergers & Acquisitions

HSMN NewsFeed - 19 Aug 2011
Verathon(R) Introduces the Heartscape 3D ECG System with 80-Lead Vest in Europe; Technology Provides More Complete Data to Help Diagnose Acute Myocardial Infarction (MI)
Devices Cardiology Monitoring

HSMN NewsFeed - 6 Jul 2011
Vasomedical Receives FDA 510(k) Clearance on Two Additional BIOX(TM) Monitors
Devices Monitoring Cardiology FDA

HSMN NewsFeed - 18 May 2011
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
Devices Interventional Cardiology

HSMN NewsFeed - 7 Apr 2011
NewCardio Study Shows my3KG Improves Diagnostic Accuracy in Diabetics With Acute Myocardial Infarction
Devices Diagnostics Cardiology Endocrinology

HSMN NewsFeed - 17 Mar 2011
STENTYS Expands Operations into Four Additional European Countries
Devices Interventional Cardiology Distribution

HSMN NewsFeed - 2 Mar 2011
Vasomedical Positioned to Seek Increased Reimbursement Coverage for EECP(R) Therapy
Devices Cardiology Reimbursement Personnel

HSMN NewsFeed - 14 Feb 2011
ADVENTRX Signs Definitive Agreement to Acquire SynthRx Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 31 Jan 2011
Baxter Introduces OLIMEL in Canada as the First Triple-Chamber Bag for Nutrition
Devices

HSMN NewsFeed - 10 Jan 2011
Bioheart Reports Positive Results for Adipose Derived Stem Cells in Critical Limb Ischemia
Regenerative Medicine Wound Care

HSMN NewsFeed - 5 Jan 2011
FDA Extends Marketing Exclusivity for INOMAX(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 9 Dec 2010
STENTYS begins large-scale, "real life" study with its self-apposing stent for treatment of Heart Attacks
Devices Interventional Cardiology

HSMN NewsFeed - 30 Oct 2010
APP Pharmaceuticals Announces Approval of Metoprolol Tartrate Injection, USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 Sep 2010
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
Devices Interventional Cardiology

HSMN NewsFeed - 28 Sep 2010
Medtronic's Insertable Cardiac Monitor Documented Arrhythmias in Post-Heart Attack Patients
Devices Monitoring Cardiology

HSMN NewsFeed - 22 Sep 2010
Stentys Self-Apposing Stent Proves Superior to Conventional Treatment of Acute Myocardial Infarction
Devices Interventional Cardiology

HSMN NewsFeed - 22 Sep 2010
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
Devices Interventional Cardiology

HSMN NewsFeed - 21 Sep 2010
PROMUS(R) Element Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries
Devices Regulatory Interventional Cardiology

HSMN NewsFeed - 21 Sep 2010
Athersys Receives Orphan Drug Designation for MultiStem in Graft vs. Host Disease
Regenerative Medicine FDA

HSMN NewsFeed - 20 Sep 2010
Athersys Announces Groundbreaking Data Showing Neuroprotective Effects of MultiStem Therapy for Traumatic Brain Injury
Regenerative Medicine Neurology

HSMN NewsFeed - 31 Aug 2010
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
Devices Interventional Cardiology

HSMN NewsFeed - 27 Aug 2010
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 26 Jul 2010
FDA Approves Tribenzor, A New Three-In-One Combination Product for the Treatment of High Blood Pressure
Biopharmaceuticals FDA

HSMN NewsFeed - 15 Jul 2010
Stentys completes enrollment in clinical study of its breakthrough stent to treat Acute Myocardial Infarction
Devices Interventional Cardiology

HSMN NewsFeed - 15 Jul 2010
Ikaria(R) Names Chief Science Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 Jun 2010
Vasomedical Announces Reorganization of Its Board of Directors
Devices Cardiology Personnel

HSMN NewsFeed - 24 Jun 2010
t2cure's Cellular Therapeutic Receives Orphan Drug Designation from FDA, EMA Recommendation for Buerger's Disease
Biopharmaceuticals Regenerative Medicine FDA Regulatory

HSMN NewsFeed - 1 Jun 2010
Ikaria(R) Names New Head of Research & Development
Biopharmaceuticals Personnel

HSMN NewsFeed - 26 May 2010
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Excellent Safety and Clinical Outcomes in High-Risk Elderly Patients
Devices Interventional Cardiology

HSMN NewsFeed - 14 Apr 2010
Bioheart Commenced Successful Regenerative Stem Cell Treatments with Latin American Patients Having Congestive Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 9 Apr 2010
Vasomedical Announces FDA 510(k) Clearance on the First Combined ECG Holter and Ambulatory Blood Pressure Monitoring System
Devices Monitoring FDA

HSMN NewsFeed - 16 Mar 2010
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents at One Year Compared to Bare-Metal Stents in Diabetic Patients Experiencing Heart Attack
Devices Interventional Cardiology

HSMN NewsFeed - 5 Mar 2010
Stentys self-expanding stent receives CE Marking to treat acute coronary syndrome (ACS)
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 24 Feb 2010
New Study Demonstrates Effectiveness of Prochymal as a Rescue Therapy for Pediatric Patients with Severe Graft vs. Host Disease
Biopharmaceuticals

HSMN NewsFeed - 15 Feb 2010
Stentys Drug-Eluting Self-Expanding Coronary Stent Shows 4% Restenosis in Complex Lesions
Devices Interventional Cardiology

HSMN NewsFeed - 9 Feb 2010
Volcano Corporation Completes Acquisition of Lumen Biomedical's Xtract(TM) Thrombus Aspiration Catheter
Devices Interventional Cardiology Acquisitions

HSMN NewsFeed - 4 Feb 2010
Bioheart Launches First US FDA Approved Clinical Trial that Tests Gene-Modified Stem Cell Therapy in Patients with Congestive Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 11 Jan 2010
Stem Cell Company t2cure Appoints Dr Petra Rueck and Susanne Knigge as Co-CEOs
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 4 Dec 2009
First patient enrolled in randomized study of Stentys self-expanding stent vs. conventional stent to treat acute myocardial infarction (AMI)
Devices Interventional Cardiology

HSMN NewsFeed - 20 Nov 2009
Pfizer Receives FDA Approval For Geodon(R) (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Oct 2009
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 25 Sep 2009
Study Shows Superior Efficacy for TAXUS(R) Express(R) Stents Compared to Bare-Metal Stents in Heart Attack Patients at Two Years
Devices Interventional Cardiology

HSMN NewsFeed - 22 Sep 2009
Stentys Discloses Results for World's First Clinical Study to Treat Acute Myocardial Infarction (AMI) with a Self-Expanding Stent
Devices Interventional Cardiology

HSMN NewsFeed - 22 Sep 2009
Abiomed Presents Results from USpella; First U.S. Registry Data Evaluating 181 Patients from 16 Centers with IRB Approval
Devices Interventional Cardiology

HSMN NewsFeed - 8 Sep 2009
Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
Biopharmaceuticals

HSMN NewsFeed - 28 Aug 2009
Stentys appoints Vice President of Sales and Marketing
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 8 Jul 2009
Stentys receives CE Mark approval
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 9 Jun 2009
Roche to Commence Phase III Trials with Innovative Treatment Designed to Lower Cardiovascular Risk in Diabetes Patients with Recent Heart Attack
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 1 Jun 2009
BioLineRx Announces Positive Preliminary Results From the Phase I/II Trial of BL-1040, the First Injectable Device Addressing Pathological Cardiac Remodeling
Devices Interventional Cardiology

HSMN NewsFeed - 19 May 2009
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 14 May 2009
Control Medical Closes Series A Financing with Strategic Investors
Devices Surgery Venture Capital

HSMN NewsFeed - 13 May 2009
AZOR(R) Receives FDA Approval as First-Line Treatment for High Blood Pressure
Biopharmaceuticals FDA

HSMN NewsFeed - 8 May 2009
New Data Shows AZOR(R) (Amlodipine and Olmesartan Medoxomil) Significantly Improves 24-Hour Ambulatory Blood Pressure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Apr 2009
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients
Devices Interventional Cardiology

HSMN NewsFeed - 8 Apr 2009
World-First Launch of New Heart Drug
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 31 Mar 2009
Results from Medtronic-Supported Clinical Trial Assessing Use of Implantable Cardiac Devices in Certain Heart Attack Patients Show Reduction in Sudden Cardiac Death
Devices Cardiology

HSMN NewsFeed - 20 Mar 2009
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Biopharmaceuticals Cardiology

HSMN NewsFeed - 12 Mar 2009
Acute myocardial infarction (AMI) successfully treated with Stentys self-expanding platform, solving stent-malapposition
Devices Interventional Cardiology

HSMN NewsFeed - 11 Mar 2009
Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
Devices Interventional Cardiology

HSMN NewsFeed - 25 Feb 2009
Life-Saving TandemHeart from CardiacAssist Has Now Been Adopted by 100 of the Nation's Elite Cardiac Centers, Including All of the Top-10 as Ranked by U.S. News & World Report
Devices Cardiology

HSMN NewsFeed - 12 Feb 2009
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Regenerative Medicine Cardiology

HSMN NewsFeed - 11 Feb 2009
CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Now Approved in the European Union for Treatment of Patients With Diabetes
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 15 Jan 2009
Osiris Receives FDA Clearance to Broaden Prochymal Expanded Access Program
Regenerative Medicine FDA

HSMN NewsFeed - 15 Jan 2009
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
Regenerative Medicine FDA

HSMN NewsFeed - 8 Dec 2008
MGuard(TM) Coronary Stent System Approved in Israel
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 5 Dec 2008
Osiris Receives Approval for Prochymal Expanded Access Program in Canada
Biopharmaceuticals Regenerative Medicine Regulatory

HSMN NewsFeed - 8 Oct 2008
Datascope Announces New Clinical Trial of Intra-Aortic Balloon Counterpulsation in Patients With Acute Myocardial Infarction to Expand Market Utilization
Devices Cardiology

HSMN NewsFeed - 30 Sep 2008
OrthoLogic Corp. Announces New Company Name: Capstone Therapeutics
Biopharmaceuticals

HSMN NewsFeed - 25 Sep 2008
Recent Research Shows Significant Benefits in Acute Ischaemic Stroke With Actilyse(R) Beyond Currently Approved Three Hour Treatment Window
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Aug 2008
CYPHER SELECT(R) Plus Sirolimus-eluting Coronary Stent Receives CE Mark Approval for Treatment of Heart Attacks
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 7 Aug 2008
OrthoLogic Announces Chrysalin (TP508) Demonstrates Significant Benefit in a Pre-Clinical Model of Acute Heart Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 28 Jul 2008
Roche and Response Biomedical Corporation Aim to Reduce 'Vein-to-Brain' Time with New Point-of-Care Cardiac Tests
Diagnostics Cardiology

HSMN NewsFeed - 5 Jun 2008
Spectranetics Enrolls First Patients in TAAMI Trial
Devices Cardiology

HSMN NewsFeed - 22 May 2008
Results Published in New England Journal of Medicine Show Angiomax Improved Net Clinical Outcomes and Resulted in Improved Survival Rates in the Most Severe Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 15 May 2008
International Endeavor Registry Reports Safety and Performance of Medtronic Drug-Eluting Stent in Diverse Patient Population
Devices Interventional Cardiology

HSMN NewsFeed - 15 May 2008
Multiple Clinical Data Presentations at EuroPCR 2008 Support Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) as Safe Alternative to Drug-Eluting Stents
Devices Interventional Cardiology

HSMN NewsFeed - 13 May 2008
Bristol-Myers Squibb and KAI Pharmaceuticals Enter Global Alliance to Develop and Commercialize KAI-9803 for Cardiovascular Disease
Biopharmaceuticals

HSMN NewsFeed - 13 May 2008
St. Jude Medical Announces Start of Landmark DETERMINE ICD Study
Devices Cardiology

HSMN NewsFeed - 13 May 2008
Thrombus Aspiration before Stenting Benefits Patients Suffering Myocardial Infarction, Study Shows
Devices Interventional Cardiology

HSMN NewsFeed - 12 May 2008
Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology

HSMN NewsFeed - 3 Apr 2008
Medicure Comments on Positive AGGRASTAT Results Presented at the American College of Cardiology Annual Scientific Session
Biopharmaceuticals Cardiology

HSMN NewsFeed - 30 Mar 2008
Heart Attack Patients Benefit From Thrombus Aspiration Prior to Stenting, Study Shows
Devices Interventional Cardiology

HSMN NewsFeed - 30 Mar 2008
BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 30 Mar 2008
Large Study Gives Nod to Drug-Eluting Stents in Heart Attack
Devices Interventional Cardiology

HSMN NewsFeed - 30 Mar 2008
Device That Clears Debris From Artery Aids Blood Flow in PCI
Devices Interventional Cardiology

HSMN NewsFeed - 24 Mar 2008
First Patient Successfully Undergoes Breakthrough Treatment for Acute Myocardial Infarction Developed by BioLineRx
Biopharmaceuticals Cardiology

HSMN NewsFeed - 17 Mar 2008
Abiomed Receives Conditional FDA Approval for Impella 2.5 Study for Acute Myocardial Infarction (AMI) Patients
Devices Cardiology FDA

HSMN NewsFeed - 11 Mar 2008
Life Recovery Systems Study of Heart Attack With ThermoSuit(R) System
Devices Cardiology FDA

HSMN NewsFeed - 4 Mar 2008
TherOx Raises $30 Million in Preferred Equity Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 25 Feb 2008
Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations
Regenerative Medicine Personnel

HSMN NewsFeed - 15 Feb 2008
OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
Devices Interventional Cardiology

HSMN NewsFeed - 4 Feb 2008
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
Biopharmaceuticals Acquisitions Cardiology

HSMN NewsFeed - 7 Jan 2008
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
Regenerative Medicine Cardiology

HSMN NewsFeed - 31 Dec 2007
Abiomed Announces Update on European Growth Strategy
Devices Cardiology

HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 20 Dec 2007
Athersys Receives IND Authorization for MultiStem in Acute Myocardial Infarction
Regenerative Medicine Cardiology

HSMN NewsFeed - 11 Dec 2007
GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 11 Dec 2007
Heartscape Technologies Appoints Former Medtronic Executive to Role as Chairman and Independent Director
Devices Personnel

HSMN NewsFeed - 3 Dec 2007
Texas Heart Institute at St. Luke's Episcopal Hospital Participates in Ground-Breaking Heart Recovery Technology Study
Devices Cardiology

HSMN NewsFeed - 26 Nov 2007
Corgenix Releases Clinical Trial Data on AtherOx(TM)
Diagnostics

HSMN NewsFeed - 14 Nov 2007
Lev Pharmaceuticals Expands Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 24 Oct 2007
Angiomax(R) / Angiox(R) (bivalirudin) Significantly Improved Net Outcomes in Heart Attack Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 23 Oct 2007
Medtronic Trials Confirm Ability of Interceptor(R) Coronary Filter System and Export(R) Aspiration Catheter to Reduce Major Cardiac Events
Devices Interventional Cardiology

HSMN NewsFeed - 23 Oct 2007
TherOx(TM) AMIHOT II Pivotal Trial Meets Endpoints
Devices Interventional Cardiology

HSMN NewsFeed - 21 Oct 2007
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 15 Oct 2007
Celera and Collaborators Identify a Five-Gene Genetic Risk Score(TM) That Predicts Risk of Coronary Heart Disease
Diagnostics Cardiology

HSMN NewsFeed - 1 Oct 2007
TherOx(TM) Announces Completion of Pivotal Trial
Devices Interventional Cardiology

HSMN NewsFeed - 27 Sep 2007
AZOR(TM) Receives FDA Approval for Treatment of High Blood Pressure
Biopharmaceuticals FDA

HSMN NewsFeed - 27 Sep 2007
FDA Approves New 300mg Loading Dose Tablet for PLAVIX(R) (clopidogrel bisulfate)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 10 Sep 2007
Lev Pharmaceuticals Meets Primary Endpoint in Pivotal Phase III Prophylactic Trial for Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 2 Sep 2007
New Study Findings Confirm CLEXANE(R)/LOVENOX(R) Long-Term Clinical Benefit in Patients Suffering From Acute Coronary Syndrome
Biopharmaceuticals Cardiology

HSMN NewsFeed - 2 Sep 2007
Medtronic to Present Key Clinical Evidence at European Society of Cardiology Congress
Devices Cardiology Monitoring

HSMN NewsFeed - 30 Aug 2007
Abiomed Receives Conditional FDA Approval for Impella 2.5 Pivotal Study at up to 150 Hospitals
Devices Cardiology

HSMN NewsFeed - 31 Jul 2007
RegeneRx Biopharmaceuticals, Inc. Updates Clinical Trials Program
Biopharmaceuticals Wound Care

HSMN NewsFeed - 31 Jul 2007
Lev Pharmaceuticals Submits Biologics License Application for Cinryze(TM)
Biopharmaceuticals FDA

HSMN NewsFeed - 26 Jun 2007
Lev Pharmaceuticals, Inc. Announces Completion of Marketing and Sales Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jun 2007
Exforge(R) Receives Final US Approval as New and Powerful Treatment Option for Patients With High Blood Pressure
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Jun 2007
Kensey Nash Announces Results of EU Coronary Study Using the Thromcat(TM) Thrombectomy Catheter System
Devices Interventional Cardiology

HSMN NewsFeed - 12 Jun 2007
Response Biomedical Receives Approval to Market NT-proBNP Congestive Heart Failure Marker Test in Canada
Diagnostics Cardiology Regulatory

HSMN NewsFeed - 5 Jun 2007
Health Canada's approval of an expanded indication for PLAVIX(R) (clopidogrel bisulfate) now offers protection from all types of heart attacks
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 31 May 2007
Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of C1-Esterase Inhibitor for Hereditary Angioedema
Biopharmaceuticals

HSMN NewsFeed - 24 May 2007
ZOLL Receives Clearance to Market E Series with See-Thru CPR Technology
Devices Cardiology FDA

HSMN NewsFeed - 24 May 2007
Boston Scientific Receives CE Mark for TAXUS(R) Liberte(TM) Long Stent
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 21 May 2007
Five-Year Fractional Flow Reserve Data Confirms Benefit of Deferral of Stenting
Devices Interventional Cardiology

HSMN NewsFeed - 18 May 2007
FDA Approves Lovenox(R) (Enoxaparin Sodium Injection) for the Most Severe Type of Heart Attack
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 18 May 2007
Medtronic Announces Schedule of Activities at EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 14 May 2007
CV Therapeutics Submits New Drug Application For Regadenoson
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 8 May 2007
Amorcyte Cardiac Cell Therapy Trial Completes Second of Four Phases
Regenerative Medicine Cardiology

HSMN NewsFeed - 30 Apr 2007
Cardiome Announces In-Licensing Agreement With Eli Lilly and Company
Biopharmaceuticals Licensing

HSMN NewsFeed - 24 Apr 2007
Heartscape Technologies Announces Close of Series B Funding
Devices Cardiology Venture Capital

HSMN NewsFeed - 23 Apr 2007
Abiomed Completes Enrollment of Pilot Clinical Trial for Impella 2.5 Circulatory Support System
Devices Cardiology

HSMN NewsFeed - 28 Mar 2007
Abiomed Announces Data on Impella 2.5 for Improved Cardiac Function for Pre-Shock Acute Myocardial Infarction
Devices Cardiology

HSMN NewsFeed - 25 Mar 2007
KAI Pharmaceuticals Presents Encouraging Phase 1/2 Results of a Novel Treatment for Heart Attack
Biopharmaceuticals Interventional Cardiology

HSMN NewsFeed - 8 Mar 2007
t2cure Appoints Dr. Manfred Ruediger as CEO
Regenerative Medicine Personnel

HSMN NewsFeed - 19 Feb 2007
The Medicines Company Supports Landmark Patient Observational Study and Clinical Survey on Acute Severe Hypertension
Biopharmaceuticals Cardiology

HSMN NewsFeed - 12 Feb 2007
Multiple Articles in the New England Journal of Medicine Confirm On-Label, Long-Term Safety and Efficacy of the CYPHER(R) Sirolimus-Eluting Coronary Stent Compared to Bare Metal Stents
Devices Interventional Cardiology

HSMN NewsFeed - 7 Feb 2007
FDA Grants Priority Review to Lovenox(R) (Enoxaparin Sodium Injection) Supplemental New Drug Application (sNDA) for Acute Heart Attack
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Feb 2007
Study Favors Drug-Eluting Stents Over Bare-Metal Stents in Key Patient Outcomes
Devices Interventional Cardiology

HSMN NewsFeed - 2 Jan 2007
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 20 Dec 2006
Abiomed Announces FDA 510(k) Clearance for New Intra-Aortic Balloon and Development of Integrated Console, the iPulse, for the Balloon, BVS 5000 and AB5000
Devices Cardiology FDA

HSMN NewsFeed - 19 Dec 2006
CardioMeter's Novel Non-Invasive Device for Physiological Assessment of Significant Coronary Artery Disease (CAD) Presented at Innovations in Cardiovascular Interventions (ICI) Meeting in Tel Aviv
Devices Cardiology

HSMN NewsFeed - 12 Dec 2006
Kaiser Permanente Reports New Data on Drug-eluting Stents
Devices Interventional Cardiology

HSMN NewsFeed - 7 Dec 2006
Radiant Medical Trial Shows Promising Results in Preventing Kidney Damage
Devices

HSMN NewsFeed - 4 Dec 2006
Largest Prospective Study of Microvolt T-Wave Alternans Demonstrates This Technology's Predictive Value for Sudden Cardiac Death in Patients With Preserved Left Ventricular Function After Acute Myocardial Infarction
Devices Cardiology

HSMN NewsFeed - 4 Dec 2006
Regadenoson Meets Primary Endpoint in Second Phase 3 Clinical Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Nov 2006
KAI Pharmaceuticals Appoints Dr. Dirk Mendel as Vice President, Pharmacology & Preclinical Pharmacokinetics and Pharmacodynamics
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Nov 2006
Clinical Studies to be Presented at American Heart Association Scientific Sessions Demonstrate Growing Body of Efficacy and Safety Data for the CYPHER(R) Sirolimus-Eluting Coronary Stent
Devices Interventional Cardiology

HSMN NewsFeed - 24 Oct 2006
Cardium Reports on Positive Effects of Hypothermia Following Heart Attack and Announces Clinical Study to Be Co-Sponsored by Swedish Cardiology Center
Devices Interventional Cardiology

HSMN NewsFeed - 26 Sep 2006
CV Therapeutics Completes MERLIN TIMI-36 Study
Biopharmaceuticals Cardiology

HSMN NewsFeed - 19 Sep 2006
Medtronic Micro-Driver Coronary Stent Approved in Japan
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 19 Sep 2006
Benefits of Vasomedical's EECP Therapy in Heart Failure Presented at the 10th Annual HFSA Scientific Meeting
Devices Cardiology

HSMN NewsFeed - 13 Sep 2006
Study in New England Journal of Medicine Suggests Heart Attack Patients Fare Better with CYPHER(R) Sirolimus-eluting Coronary Stents Than Bare Metal Stents
Devices Interventional Cardiology

HSMN NewsFeed - 13 Sep 2006
Premier Inc. Signs Agreement
Group Purchasing Hospitals & Healthcare Systems

HSMN NewsFeed - 7 Sep 2006
European commission expands indication for PLAVIX® (clopidogrel bisulfate) offering new option for patients with most severe type of heart attack
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 24 Jul 2006
Response Biomedical Completes US Distribution Network For RAMP Cardiovascular Products
Diagnostics Cardiology Distribution

HSMN NewsFeed - 13 Jul 2006
CoGenesys Receives FDA Clearance to Commence Clinical Trials of Cardeva in Patients with Chronic Heart Failure
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 5 Jul 2006
FDA Clears Lumen Biomedical Catheter for Removing Clots from Arteries
Devices Interventional FDA

HSMN NewsFeed - 27 Jun 2006
FDA Approves Abiomed's IDE for IMPELLA 5.0 Minimally Invasive Cardiac Support Systems
Devices Cardiology FDA

HSMN NewsFeed - 26 Jun 2006
Bioheart, Inc. to Receive Funds From a Grant Awarded by the State of Ohio to Further Develop Adult Stem Cell Therapies
Regenerative Medicine Cardiology

HSMN NewsFeed - 25 May 2006
Sorin Group: Six Month Clinical Results of e-Janus Registry
Devices Interventional Cardiology

HSMN NewsFeed - 16 May 2006
TAXUS(R) Liberte(TM) Stent System Receives European Approval for Three Complex Coronary Procedures
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 11 May 2006
Medtronic Announces Schedule of Activities At EuroPCR
Devices Interventional Cardiology

HSMN NewsFeed - 20 Feb 2006
Sorin Group: Janus Tacrolimus Eluting Carbostent Demonstrates Excellent Safety Profile and Clinical Efficacy in "Real-World" Patients, Particularly in Those With Acute Myocardial Infarction
Devices Interventional Cardiology

Return to NewsFeed

Additional items found! 210

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 210 additional stories matching:
Acute Myocardial Infarction
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.